Iboga (Tabernanthe Iboga) Essence 1:25 – Root Bark from Cameroon – 5ml

Iboga root bark in a liquid specimen

Sacred Plants Iboga essence is a liquid preparation made with Tabernanthe iboga root bark from Cameroon, carrying the manufacturer’s 1:25 designation.

The plant behind it belongs to Central Africa’s forest understorey and to a long history of religious and botanical knowledge. Its root bark is known as sacred wood in Bwiti traditions. This modern bottled preparation has its own formulation; the cultural history belongs to the source plant and the communities that have worked with it.

The chemistry of a liquid preparation

Iboga’s root bark contains a mixture of indole alkaloids, with ibogaine the best studied. Turning botanical material into a liquid preparation raises specific chemical questions: which constituents enter the liquid, in what proportions, and how they are measured. These depend on the starting material and the preparation process, so a formulation ratio and a laboratory assay provide different kinds of information.

The 1:25 designation identifies this preparation within the Sacred Plants range. An ibogaine concentration must come from a measurement of ibogaine itself; a total-alkaloid figure describes a broader mixture. Keeping those terms distinct is essential when comparing liquid specimens with whole bark or isolated research compounds.

What ibogaine research examines

Ibogaine’s scientific interest comes partly from its unusual range of interactions with brain signalling systems. Research describes activity involving opioid and NMDA receptors, among other targets, rather than a single simple mechanism. Scientists also study noribogaine, the active compound formed when the body metabolises ibogaine. The two have different time courses and pharmacological profiles.

Human studies have examined reported dreamlike imagery, autobiographical memory and changes in symptoms in defined research or clinical settings. These findings concern the substances, protocols and people studied. They do not establish equivalent effects for this essence. In the same way, online discussion of “microdosing” does not provide a scientific characterisation of this particular preparation.

For the wider botanical and cultural account, explore our Iboga collection.

Sold solely as a botanical specimen, not for human consumption. Published research documents serious cardiac risks associated with Iboga and ibogaine. Safety reference.

Selected references

• Cherian and colleagues (2024) — Ibogaine pharmacology and an observational clinical protocol.
• RIVM (2024) — Ibogaine, noribogaine and the assessment of Iboga preparations.
• Brown, Noller & Denenberg (2019) — Reports of ibogaine’s subjective effects.

This product is sold as a botanical specimen. Information on traditional, cultural and reported uses is provided for educational and ethnobotanical purposes only and is not a recommendation for any particular use. This product is not intended to diagnose, treat, cure or prevent any disease.